I am leading a research group at the University of Oxford.
My group focusses on two pivotal research aspects of HPV:
1) the inability of the immune system to tackle the infection,
2) the development of potential therapeutics to treat persistent infections.
I am an expert in my field and as such I took on the role of Chief-Investigator of a multinational therapeutic HPV vaccine trial - the first in-human trial of a vaccine developed at Oxford University - which could make a difference to millions of women and men suffering from persistent HPV infections.